Nuveen Asset Management, LLC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 159 filers reported holding VIKING THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$10,744,756
-71.6%
202,693
-56.0%
0.00%
-72.7%
Q1 2024$37,811,806
+659.2%
461,082
+72.3%
0.01%
+450.0%
Q4 2023$4,980,408
+70.2%
267,620
+1.3%
0.00%
+100.0%
Q3 2023$2,925,624
-31.8%
264,284
-0.1%
0.00%0.0%
Q2 2023$4,289,085
+1985587.5%
264,595
+1943.5%
0.00%
Q1 2023$216
-100.0%
12,948
-95.1%
0.00%
Q1 2022$855,000
-76.0%
263,132
-66.5%
0.00%
-100.0%
Q4 2021$3,568,000
-52.1%
786,013
-29.4%
0.00%
-50.0%
Q3 2021$7,448,000
+338.6%
1,113,372
+292.7%
0.00%
+100.0%
Q2 2021$1,698,000
-9.5%
283,548
-4.5%
0.00%0.0%
Q1 2021$1,877,000
+7.5%
296,758
-4.3%
0.00%0.0%
Q4 2020$1,746,000
-40.1%
310,020
-38.1%
0.00%0.0%
Q3 2020$2,917,000
+62.9%
501,188
+101.7%
0.00%0.0%
Q2 2020$1,791,000
+50.4%
248,470
-2.3%
0.00%0.0%
Q1 2020$1,191,000
-41.8%
254,426
-0.2%
0.00%0.0%
Q4 2019$2,045,000
-29.6%
254,959
-39.6%
0.00%0.0%
Q3 2019$2,906,000
+25.7%
422,401
+51.7%
0.00%0.0%
Q2 2019$2,312,000
+264.1%
278,525
+235.7%
0.00%
-75.0%
Q4 2018$635,000
+29.1%
82,960
+193.9%
0.00%
+33.3%
Q3 2018$492,00028,2290.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders